Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Neuroblastoma
Study Phase
Phase 3
Study Completion Date
April 2014
NCT01041638Uploaded 09-23-2020
Access via NCI by Request
PDS UID: nci-data-426
A Comprehensive Safety Trial of Chimeric Antibody 14.18 (Ch14.18) With GM-CSF, IL-2 and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy
Files: NCT01041638-D1
Data DictionaryNCT01041638-D1-Data-Dictionary_5.pdf
DATANCT01041638-D1-Dataset.CSV
OTHERREADME.pdf
Files: NCT01041638-D2
Data DictionaryNCT01041638-D2-Data-Dictionary_3.pdf
DATANCT01041638-D2-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01041638-D3
Data DictionaryNCT01041638-D3-Data-Dictionary_3.pdf
DATANCT01041638-D3-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01041638-D4
Data DictionaryNCT01041638-D4-Data-Dictionary_3.pdf
DATANCT01041638-D4-Dataset_4.csv
OTHERREADME.pdf